Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
409 participants
INTERVENTIONAL
2007-08-31
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
NCT00329264
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder
NCT00329446
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder
NCT00322595
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder
NCT00389064
Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
NCT01971203
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Adjunctive Placebo Seroquel XR to anxiety treatment
Placebo
oral
2
Adjunctive Seroquel XR to anxiety treatment
quetiapine fumarate XR
oral
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
oral
quetiapine fumarate XR
oral
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documented diagnosis of Generalized Anxiety Disorder
* Female patients must not be pregnant and be willing to use a reliable method of birth control
* Be able to understand and comply with study requirements
Exclusion Criteria
* Moderate to severe depression
* Other clinically relevant diseases, as judged by the study doctor
* Medication that you are taking, as judged by the study doctor
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Brecher, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Birmingham, Alabama, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Beverly Hills, California, United States
Research Site
Encino, California, United States
Research Site
Fresno, California, United States
Research Site
La Mesa, California, United States
Research Site
Oceanside, California, United States
Research Site
Redlands, California, United States
Research Site
San Diego, California, United States
Research Site
San Francisco, California, United States
Research Site
Sherman Oaks, California, United States
Research Site
Bradenton, Florida, United States
Research Site
Dayton, Florida, United States
Research Site
Hialeah, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Maitland, Florida, United States
Research Site
Miami, Florida, United States
Research Site
North Miami, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
West Palm Beach, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Columbus, Georgia, United States
Research Site
Chicago, Illinois, United States
Research Site
Lafayette, Indiana, United States
Research Site
Merrillville, Indiana, United States
Research Site
Terre Haute, Indiana, United States
Research Site
Prairie Village, Kansas, United States
Research Site
Owenboro, Kentucky, United States
Research Site
New Orleans, Louisiana, United States
Research Site
Rockville, Maryland, United States
Research Site
Boston, Massachusetts, United States
Research Site
Cherry Hill, New Jersey, United States
Research Site
Clementon, New Jersey, United States
Research Site
Brooklyn, New York, United States
Research Site
Cedarhurst, New York, United States
Research Site
Fresh Meadows, New York, United States
Research Site
New York, New York, United States
Research Site
Rochester, New York, United States
Research Site
Staten Island, New York, United States
Research Site
Toledo, Ohio, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Portland, Oregon, United States
Research Site
Salem, Oregon, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Memphis, Tennessee, United States
Research Site
Houston, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
Witchita Falls, Texas, United States
Research Site
Richmond, Virginia, United States
Research Site
Bellevue, Washington, United States
Research Site
Seattle, Washington, United States
Research Site
Spokane, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Khan A, Atkinson S, Mezhebovsky I, She F, Leathers T, Pathak S. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study. Ann Clin Psychiatry. 2014 Feb;26(1):3-18.
Khan A, Atkinson S, Mezhebovsky I, She F, Leathers T, Pathak S. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study. Ann Clin Psychiatry. 2013 Nov;25(4):E7-22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D1441L00016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.